References

Chae C. Porcine respiratory disease complex: interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae. Vet J.. 2016; 212:1-6 https://doi.org/10.1016/j.tvjl.2015.10.030

Ferraz MES, Almeida HMS, Storino GY Lung consolidation caused by Mycoplasma hyopneumoniae has a negative effect on productive performance and economic revenue in finishing pigs. Prev Vet Med. 2020; 182 https://doi.org/10.1016/j.prevetmed.2020.105091

Fraile L, Alegre A, López-Jiménez R, Nofrarías M, Segalés J. Risk factors associated with pleuritis and cranio-ventral pulmonary consolidation in slaughter-aged pigs. Vet J.. 2010; 184:(3)326-333 https://doi.org/10.1016/j.tvjl.2009.03.029

Garcia-Morante B, Segalés J, Fraile L Assessment of Mycoplasma hyopneumoniae-induced pneumonia using different lung lesion scoring systems: a comparative review. J Comp Pathol.. 2016; 154:(2-3)125-134 https://doi.org/10.1016/j.jcpa.2015.11.003

Hannan PCT, Bhogal BS, Fish JP. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses. Res Vet Sci.. 1982; 33:(1)76-88 https://doi.org/10.1016/S0034-5288(18)32364-6

Holst S, Yeske P, Pieters M. Elimination of Mycoplasma hyopneumoniae from breed-to-wean farms: A review of current protocols with emphasis on herd closure and medication. J Swine Health Prod.. 2015; 23:(6)321-330

Leal Zimmer FMA, Paes JA, Zaha A, Ferreira HB. Pathogenicity and virulence of Mycoplasma hyopneumoniae. Virulence. 2020; 11:(1)1600-1622 https://doi.org/10.1080/21505594.2020.1842659

Madec F, Kobisch M. Bilan lesionnel des poumons de porcs charcutiers a l'abattoir. J Rech Porc Fr.. 1982; 14:405-412

Maes D, Deluyker H, Verdonck M Herd factors associated with the seroprevalences of four major respiratory pathogens in slaughter pigs from farrow-to-finish pig herds. Vet Res.. 2000; 31:(3)313-327 https://doi.org/10.1051/vetres:2000122

Maes DG, Deluyker H, Verdonck M Non-infectious factors associated with macroscopic and microscopic lung lesions in slaughter pigs from farrow-to-finish herds. Vet Rec.. 2001; 148:(2)41-46 https://doi.org/10.1136/vr.148.2.41

Maes D, Verbeke W, Vicca J, Verdonck M, de Kruif A. Benefit to cost of vaccination against Mycoplasma hyopneumoniae in pig herds under Belgian market conditions from 1996 to 2000. Livest Prod Sci.. 2003; 83:(1)85-93 https://doi.org/10.1016/S0301-6226(03)00039-3

Maes D, Segales J, Meyns T, Sibila M, Pieters M, Haesebrouck F. Control of Mycoplasma hyopneumoniae infections in pigs. Vet Microbiol.. 2008; 126:(4)297-309 https://doi.org/10.1016/j.vetmic.2007.09.008

Maes D, Sibila M, Kuhnert P, Segalés J, Haesebrouck F, Pieters M. Update on Mycoplasma hyopneumoniae infections in pigs: Knowledge gaps for improved disease control. Transbound Emerg Dis.. 2018; 65:110-124 https://doi.org/10.1111/tbed.12677

Marois C, Gottschalk M, Morvan H, Fablet C, Madec F, Kobisch M. Experimental infection of SPF pigs with Actinobacillus pleuropneumoniae serotype 9 alone or in association with Mycoplasma hyopneumoniae. Vet Microbiol.. 2009; 135:(3-4)283-291 https://doi.org/10.1016/j.vetmic.2008.09.061

Michiels A, Arsenakis I, Boyen F, Krejci R, Haesebrouck F, Maes D. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains. BMC Vet Res.. 201713:(1) https://doi.org/10.1186/s12917-017-1195-0

Opriessnig T, Thacker EL, Yu S, Fenaux M, Meng XJ, Halbur PG. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet Pathol.. 2004; 41:(6)624-640 https://doi.org/10.1354/vp.41-6-624

Ostanello F, Dottori M, Gusmara C, Leotti G, Sala V. Pneumonia disease assessment using a slaughterhouse lung-scoring method. Journal of Veterinary Medicine Series A.. 2007; 54:(2)70-75 https://doi.org/10.1111/j.1439-0442.2007.00920.x

Park C, Jeong J, Kang I, Choi K, Park SJ, Chae C. Increased fucosyl glycoconjugate by Mycoplasma hyopneumoniae enhances adherences of Pasteurella multocida type A in the ciliated epithelial cells of the respiratory tract. BMC Vet Res.. 2016; 12:(1) https://doi.org/10.1186/s12917-016-0650-7

Pieters M, Daniels J, Rovira A. Comparison of sample types and diagnostic methods for in vivo detection of Mycoplasma hyopneumoniae during early stages of infection. Vet Microbiol.. 2017; 203:103-109 https://doi.org/10.1016/j.vetmic.2017.02.014

Saade G, Deblanc C, Bougon J Coinfections and their molecular consequences in the porcine respiratory tract. Vet Res.. 2020; 51:(1) https://doi.org/10.1186/s13567-020-00807-8

Sibila M, Pieters M, Molitor T, Maes D, Haesebrouck F, Segalés J. Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection. Vet J.. 2009; 181:(3)221-231 https://doi.org/10.1016/j.tvjl.2008.02.020

Silva GS, Yeske P, Morrison RB, Linhares DCL. Benefit-cost analysis to estimate the payback time and the economic value of two Mycoplasma hyopneumoniae elimination methods in breeding herds. Prev Vet Med.. 2019; 168:95-102 https://doi.org/10.1016/j.prevetmed.2019.04.008

Straw BE, Tuovinen VK, Bigras-Poulin M. Estimation of the cost of pneumonia in swine herds. J Am Vet Med Assoc.. 1989; 195:(12)1702-1706

Taylor DJ. Pig diseases, 6th Revised edition. : Farming Press Books and Videos; 1995

Vicca J. Virulence and antimicrobial susceptibility of Mycoplasma hyopneumoniae isolates from pigs (Doctoral dissertation, Ghent University). 2005;

Wang H, Feng Z, Wu Y The effects of Mycoplasma hyopneumoniae on porcine circovirus type 2 replication in vitro PK-15 cells. Res Vet Sci.. 2016; 105:56-61 https://doi.org/10.1016/j.rvsc.2016.01.015

Yazawa S, Okada M, Ono M Experimental dual infection of pigs with an H1N1 swine influenza virus (A/Sw/Hok/2/81) and Mycoplasma hyopneumoniae. Vet Microbiol. 2004; 98:(3-4)221-228 https://doi.org/10.1016/j.vetmic.2003.11.005

Mycoplasma hyopneumoniae as a causative agent of porcine enzootic pneumonia

02 May 2021
11 mins read
Volume 26 · Issue 3
Figure 1. Pneumonic lung lesions caused by infection with M. hyopneumoniae (courtesy IZSLER, Italy).
Figure 1. Pneumonic lung lesions caused by infection with M. hyopneumoniae (courtesy IZSLER, Italy).

Abstract

Mycoplasma hyopneumoniae is a very important pathogen which causes enzootic pneumonia (EP) affecting pig herds worldwide. M. hyopneumoniae establishes itself in the respiratory system causing pathological changes, and resultant pneumonic lesions can be detected at slaughter via lung examination, appearing as red to pink lesions which resolve over time, leaving scar tissue on the lobes. Mycoplasma spp. infection can be complicated by coinfections with other pathogens such as swine influenza virus (SIV) and porcine circovirus (PCV2). These coinfections result in worsening of clinical symptoms and lung lesions, therefore increasing the impact on performance of the affected animals. Therefore, it is important that focus is placed on improving overall respiratory health and managing overall herd health, rather than just solely focusing on M. hyopneumoniae. Management practices should be implemented to control the disease, which commonly involve vaccination to reduce the impacts of the disease. Effective vaccination is important, and can be ensured by correct vaccine handling, storage and administration. The vaccine used can also play a part in the success of the vaccination programme so this should also be assessed, which can be done via lung examination and noting of clinical signs and performance parameters. When vaccination is successful, the level of lung lesions should be reduced, performance improved and consistency between batches, demonstrating that respiratory health is more stable.

Mycoplasma hyopneumoniae is one of the most important primary pathogens of the porcine respiratory system and is the causative agent of enzootic pneumonia (EP) (Fraile et al, 2010). M. hyopneumoniae is also a major contributor to development of the porcine respiratory disease complex (PRDC) (Garcia-Morante et al, 2016). M. hyopneumoniae is widespread throughout the pig population and is endemic on most farms worldwide. Pneumonic lung lesions as a result of M. hyopneumoniae are commonly observed in the slaughterhouse, with average herd level prevalence reported as 24%, ranging up to 88% (Maes et al, 2001), demonstrating the large variability observed between units depending on individual farm situation. Co-infections are very important in respiratory disease, as interaction of multiple pathogens has been shown to increase the severity of clinical signs (Saade et al, 2020) and therefore the impact on performance. Enzootic pneumonia has a large economic impact on the pig industry, primarily because of the cost of treatment, reduced performance and increased mortality as a result of secondary infections (Holst et al, 2015). Therefore, implementation of control measures is extremely important to improve animal health and consequently productivity on farm. Management practices form an integral part of this control plan, including improved biosecurity and hygiene, which may be accompanied with vaccination. There are numerous vaccines available which vary in the vaccination schedule, but the ultimate goal should be reduction of lung lesions and performance losses as a result of M. hyopneumoniae.

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.